210 related articles for article (PubMed ID: 22311342)
1. Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.
Jauhola O; Ronkainen J; Koskimies O; Ala-Houhala M; Arikoski P; Hölttä T; Jahnukainen T; Rajantie J; Örmälä T; Nuutinen M
Pediatr Nephrol; 2012 Jun; 27(6):933-9. PubMed ID: 22311342
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.
Xia Y; Mao J; Chen Y; Wang D; Cao L; Yao S; Fu H; Du L; Liu A
Pediatr Nephrol; 2011 Jul; 26(7):1083-8. PubMed ID: 21387156
[TBL] [Abstract][Full Text] [Related]
3. Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children.
Jauhola O; Ronkainen J; Koskimies O; Ala-Houhala M; Arikoski P; Hölttä T; Jahnukainen T; Rajantie J; Ormälä T; Turtinen J; Nuutinen M
Arch Dis Child; 2010 Nov; 95(11):877-82. PubMed ID: 20852275
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
[TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone or cyclosporine a in the treatment of Henoch-Schönlein nephritis: a nationwide study.
Koskela M; Jahnukainen T; Endén K; Arikoski P; Kataja J; Nuutinen M; Ylinen E
Pediatr Nephrol; 2019 Aug; 34(8):1447-1456. PubMed ID: 30955086
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: a retrospective study.
Han F; Chen LL; Ren PP; Le JY; Choong PJ; Wang HJ; Xu Y; Chen JH
J Zhejiang Univ Sci B; 2015 Sep; 16(9):772-9. PubMed ID: 26365119
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe Henoch-Schönlein nephritis: justifying more immunosuppression.
Altugan FS; Ozen S; Aktay-Ayaz N; Güçer S; Topaloğlu R; Düzova A; Ozaltin F; Beşbaş N
Turk J Pediatr; 2009; 51(6):551-5. PubMed ID: 20196388
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children.
Hattori M; Ito K; Konomoto T; Kawaguchi H; Yoshioka T; Khono M
Am J Kidney Dis; 1999 Mar; 33(3):427-33. PubMed ID: 10070905
[TBL] [Abstract][Full Text] [Related]
9. Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).
Dudley J; Smith G; Llewelyn-Edwards A; Bayliss K; Pike K; Tizard J
Arch Dis Child; 2013 Oct; 98(10):756-63. PubMed ID: 23845696
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.
Huang YJ; Yang XQ; Zhai WS; Ren XQ; Guo QY; Zhang X; Yang M; Yamamoto T; Sun Y; Ding Y
World J Pediatr; 2015 Nov; 11(4):338-45. PubMed ID: 25410673
[TBL] [Abstract][Full Text] [Related]
11. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter investigation of diagnosis and treatment of Henoch-Schonlein purpura nephritis in childhood].
Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Disease
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):881-7. PubMed ID: 24495756
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of prednisone treatment in children with IgA nephropathy and Schönlein-Henoch nephropathy according to the Waldo protocol with regard to pathomorphologic changes in renal biopsy].
Szymanik-Grzelak H; Mizerska-Wasiak M; Roszkowska-Blaim M
Pol Merkur Lekarski; 2001 Apr; 10(58):259-62. PubMed ID: 11434171
[TBL] [Abstract][Full Text] [Related]
14. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis.
Inoue CN; Chiba Y; Morimoto T; Nishio T; Kondo Y; Adachi M; Matsutani S
Clin Nephrol; 2007 May; 67(5):298-305. PubMed ID: 17542339
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
[TBL] [Abstract][Full Text] [Related]
16. Even mild cases of paediatric Henoch-Schönlein purpura nephritis show significant long-term proteinuria.
Tudorache E; Azema C; Hogan J; Wannous H; Aoun B; Decramer S; Deschênes G; Ulinski T
Acta Paediatr; 2015 Aug; 104(8):843-8. PubMed ID: 24946692
[TBL] [Abstract][Full Text] [Related]
17. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.
Lu Z; Song J; Mao J; Xia Y; Wang C
Med Sci Monit; 2017 May; 23():2333-2339. PubMed ID: 28515415
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].
Huber AM; King J; McLaine P; Klassen T; Pothos M
BMC Med; 2004 Apr; 2():7. PubMed ID: 15059282
[TBL] [Abstract][Full Text] [Related]
20. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
Ren P; Han F; Chen L; Xu Y; Wang Y; Chen J
Am J Nephrol; 2012; 36(3):271-7. PubMed ID: 22965140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]